
Susan Loring
Examiner (ID: 19014)
| Most Active Art Unit | 1806 |
| Art Unit(s) | 1641, 1806, 1802, 2899 |
| Total Applications | 317 |
| Issued Applications | 204 |
| Pending Applications | 27 |
| Abandoned Applications | 86 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 08/463891 | MONOCLONAL ANTI-HUMAN BREAST CANCER ANTIBODIES | Jun 4, 1995 | Abandoned |
Array
(
[id] => 3723028
[patent_doc_number] => 05702705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Antibody methods for the treatment of a hormone-mediated disease'
[patent_app_type] => 1
[patent_app_number] => 8/463892
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10816
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/702/05702705.pdf
[firstpage_image] =>[orig_patent_app_number] => 463892
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463892 | Antibody methods for the treatment of a hormone-mediated disease | Jun 4, 1995 | Issued |
Array
(
[id] => 3866883
[patent_doc_number] => 05837541
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Cross-protective human monoclonal antibody compositions'
[patent_app_type] => 1
[patent_app_number] => 8/464495
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20292
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837541.pdf
[firstpage_image] =>[orig_patent_app_number] => 464495
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464495 | Cross-protective human monoclonal antibody compositions | Jun 4, 1995 | Issued |
Array
(
[id] => 3625916
[patent_doc_number] => 05686259
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Assay method for the detection of 26kd TNF prohormone'
[patent_app_type] => 1
[patent_app_number] => 8/463894
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10801
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686259.pdf
[firstpage_image] =>[orig_patent_app_number] => 463894
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463894 | Assay method for the detection of 26kd TNF prohormone | Jun 4, 1995 | Issued |
Array
(
[id] => 3879928
[patent_doc_number] => 05728812
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-17
[patent_title] => 'Anti-idiotypic antibody composition for inhibiting acute complement-mediated cytotoxicity'
[patent_app_type] => 1
[patent_app_number] => 8/458274
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9230
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/728/05728812.pdf
[firstpage_image] =>[orig_patent_app_number] => 458274
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/458274 | Anti-idiotypic antibody composition for inhibiting acute complement-mediated cytotoxicity | Jun 1, 1995 | Issued |
Array
(
[id] => 3881693
[patent_doc_number] => 05723126
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Methods and compositions for therapeutic uses of a fibrin-specific monoclonal antibody'
[patent_app_type] => 1
[patent_app_number] => 8/460702
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21512
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723126.pdf
[firstpage_image] =>[orig_patent_app_number] => 460702
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460702 | Methods and compositions for therapeutic uses of a fibrin-specific monoclonal antibody | Jun 1, 1995 | Issued |
Array
(
[id] => 3883559
[patent_doc_number] => 05833986
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Methods of inhibiting the growth of neoplasia using a monoclonal antibody against .alpha. platelet derived growth factor receptor'
[patent_app_type] => 1
[patent_app_number] => 8/460279
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 8740
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/833/05833986.pdf
[firstpage_image] =>[orig_patent_app_number] => 460279
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460279 | Methods of inhibiting the growth of neoplasia using a monoclonal antibody against .alpha. platelet derived growth factor receptor | Jun 1, 1995 | Issued |
Array
(
[id] => 3866117
[patent_doc_number] => 05837496
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Merosin fragments and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/460309
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 41
[patent_no_of_words] => 14637
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837496.pdf
[firstpage_image] =>[orig_patent_app_number] => 460309
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460309 | Merosin fragments and uses thereof | Jun 1, 1995 | Issued |
Array
(
[id] => 3756650
[patent_doc_number] => 05721122
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-24
[patent_title] => 'Method comprising immunization of antigen-free mice'
[patent_app_type] => 1
[patent_app_number] => 8/460698
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21485
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/721/05721122.pdf
[firstpage_image] =>[orig_patent_app_number] => 460698
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460698 | Method comprising immunization of antigen-free mice | Jun 1, 1995 | Issued |
Array
(
[id] => 4055719
[patent_doc_number] => 05863739
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-26
[patent_title] => 'Assay and kit for the detection of .alpha. platelet derived growth factor receptor'
[patent_app_type] => 1
[patent_app_number] => 8/460069
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 8801
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/863/05863739.pdf
[firstpage_image] =>[orig_patent_app_number] => 460069
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460069 | Assay and kit for the detection of .alpha. platelet derived growth factor receptor | Jun 1, 1995 | Issued |
Array
(
[id] => 3681094
[patent_doc_number] => 05633142
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-27
[patent_title] => 'WT1 monoclonal antibodies and methods of use therefor'
[patent_app_type] => 1
[patent_app_number] => 8/456907
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9571
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/633/05633142.pdf
[firstpage_image] =>[orig_patent_app_number] => 456907
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456907 | WT1 monoclonal antibodies and methods of use therefor | May 31, 1995 | Issued |
Array
(
[id] => 3753775
[patent_doc_number] => 05843442
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Blood coagulation protein antagonists and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/453047
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8186
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843442.pdf
[firstpage_image] =>[orig_patent_app_number] => 453047
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/453047 | Blood coagulation protein antagonists and uses therefor | May 29, 1995 | Issued |
Array
(
[id] => 3693380
[patent_doc_number] => 05650300
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-22
[patent_title] => 'Method of producing monoclonal antibodies to oncofetal protein'
[patent_app_type] => 1
[patent_app_number] => 8/452252
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11805
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/650/05650300.pdf
[firstpage_image] =>[orig_patent_app_number] => 452252
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/452252 | Method of producing monoclonal antibodies to oncofetal protein | May 25, 1995 | Issued |
Array
(
[id] => 3659157
[patent_doc_number] => 05656444
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-12
[patent_title] => 'Monoclonal antibody to oncofetal protein for treating and detecting cancer'
[patent_app_type] => 1
[patent_app_number] => 8/451923
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11853
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/656/05656444.pdf
[firstpage_image] =>[orig_patent_app_number] => 451923
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451923 | Monoclonal antibody to oncofetal protein for treating and detecting cancer | May 25, 1995 | Issued |
Array
(
[id] => 3484207
[patent_doc_number] => 05474755
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-12-12
[patent_title] => 'Tumor associated monoclonal antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/449613
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10121
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/474/05474755.pdf
[firstpage_image] =>[orig_patent_app_number] => 449613
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449613 | Tumor associated monoclonal antibodies | May 23, 1995 | Issued |
Array
(
[id] => 3616950
[patent_doc_number] => 05688505
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Method for treating cancer with monoclonal antibodies to oncofetal protein'
[patent_app_type] => 1
[patent_app_number] => 8/449336
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12082
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/688/05688505.pdf
[firstpage_image] =>[orig_patent_app_number] => 449336
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449336 | Method for treating cancer with monoclonal antibodies to oncofetal protein | May 23, 1995 | Issued |
Array
(
[id] => 3888652
[patent_doc_number] => 05714589
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Method of selectively extracting osteogenic protein'
[patent_app_type] => 1
[patent_app_number] => 8/447570
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 80
[patent_no_of_words] => 36452
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/714/05714589.pdf
[firstpage_image] =>[orig_patent_app_number] => 447570
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/447570 | Method of selectively extracting osteogenic protein | May 22, 1995 | Issued |
| 08/443540 | DNA BINDING ANTIBODIES | May 17, 1995 | Abandoned |
Array
(
[id] => 4045483
[patent_doc_number] => 05874545
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'DCC antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/442977
[patent_app_country] => US
[patent_app_date] => 1995-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 8895
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874545.pdf
[firstpage_image] =>[orig_patent_app_number] => 442977
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442977 | DCC antibodies | May 16, 1995 | Issued |
Array
(
[id] => 3521359
[patent_doc_number] => 05530102
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Methods and compositions for the direct concentrated delivery of passive immunity'
[patent_app_type] => 1
[patent_app_number] => 8/441299
[patent_app_country] => US
[patent_app_date] => 1995-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6590
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/530/05530102.pdf
[firstpage_image] =>[orig_patent_app_number] => 441299
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441299 | Methods and compositions for the direct concentrated delivery of passive immunity | May 14, 1995 | Issued |